Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharina Karsten-Dafonte

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Clinical Medicine|July 27, 2022
Prioritisation of Adverse Drug Events Leading to Hospital Admission and Occurring during Hospitalisation: A RAND SurveyAnnette Haerdtlein, Anna Maria Boehmer, Katharina Karsten Dafonte, et al.
JMIR Research Protocols|June 10, 2026
Dose Recommendations for Drugs in Patients With Liver Cirrhosis (The ALIVe Study): Protocol for a Multiphase Validation and Consensus StudyKatharina Karsten Dafonte, Philipp Lutz, Christian Jansen, et al.
Clinical Drug Investigation|July 17, 2023
Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature ReviewKatharina Karsten Dafonte, Lisa Weber, Florian Chmielewski, et al.
Studies in Health Technology and Informatics|May 17, 2025
Concept of Modeling Pharmacist-Led Medication Reviews in Clinical Setting: A Knowledge Graph-Based ApproachJulia Kiesel, Katharina Karsten-Dafonte, Katrin Farker, et al.
Clinical Drug Investigation|March 10, 2026
Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert PanelKatharina Karsten Dafonte, Philipp Lutz, Christian Jansen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|July 27, 2022
Prioritisation of Adverse Drug Events Leading to Hospital Admission and Occurring during Hospitalisation: A RAND SurveyAnnette Haerdtlein, Anna Maria Boehmer, Katharina Karsten Dafonte, et al.
JMIR Research Protocols|June 10, 2026
Dose Recommendations for Drugs in Patients With Liver Cirrhosis (The ALIVe Study): Protocol for a Multiphase Validation and Consensus StudyKatharina Karsten Dafonte, Philipp Lutz, Christian Jansen, et al.
Clinical Drug Investigation|July 17, 2023
Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature ReviewKatharina Karsten Dafonte, Lisa Weber, Florian Chmielewski, et al.
Studies in Health Technology and Informatics|May 17, 2025
Concept of Modeling Pharmacist-Led Medication Reviews in Clinical Setting: A Knowledge Graph-Based ApproachJulia Kiesel, Katharina Karsten-Dafonte, Katrin Farker, et al.
Clinical Drug Investigation|March 10, 2026
Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert PanelKatharina Karsten Dafonte, Philipp Lutz, Christian Jansen, et al.
Pageof 1